712 results on '"Davison, Beth A"'
Search Results
2. High-intensity care for GDMT titration
3. Titration of Medications After Acute Heart Failure Is Safe, Tolerated, and Effective Regardless of Risk
4. Characteristics, treatment, and outcomes of early vs. late enrollees of the STRONG-HF trial
5. Enhanced Decongestive Therapy in Patients With Acute Heart Failure: JACC Review Topic of the Week
6. Safety Indicators in Patients Receiving High-intensity Care After Hospital Admission for Acute Heart Failure: The STRONG-HF Trial
7. Worsening renal function in acute heart failure in the context of diuretic response
8. Detailed Assessment of the “I Need Help” Criteria in Patients With Heart Failure: Insights From the HELP-HF Registry
9. Noninvasive measure of treatment response in non‐alcoholic steatohepatitis: Insights from EMMINENCE and meta‐analysis
10. Objectively measured medication adherence using assays for carvedilol and enalaprilat in patients with heart failure in Mozambique and Nigeria
11. POINT: Should New Drug Development in Heart Failure Focus on Patients Discharged From an Acute Heart Failure Admission? Lessons From Recent Studies
12. Hepatorenal dysfunction identifies high‐risk patients with acute heart failure: insights from the RELAX‐AHF trial
13. Reduced congestion and improved response to a fluid/sodium challenge in chronic heart failure patients after initiation of sacubitril/valsartan: The NATRIUM‐HF study
14. Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial
15. Association between in-ICU red blood cells transfusion and 1-year mortality in ICU survivors
16. Burst steroid therapy for acute heart failure: The CORTAHF randomized, open‐label, pilot trial.
17. Biologically active adrenomedullin as a marker for residual congestion and early rehospitalization in patients hospitalized for acute heart failure: Data from STRONG‐HF.
18. Outcomes of patients with heart failure with preserved ejection fraction discharged on treatment with neurohormonal antagonists after an episode of decompensation
19. Association of Early Blood Pressure Decrease and Renal Function With Prognosis in Acute Heart Failure
20. Impact of Rapid Up-Titration of Guideline-Directed Medical Therapies on Quality of Life: Insights From the STRONG-HF Trial
21. Blood pressure and intensive treatment up‐titration after acute heart failure hospitalization: Insights from the STRONG‐HF trial
22. Safety Indicators In Patients Receiving High-intensity Care After Acute Heart Failure Admission: The STRONG-HF Trial
23. Regional variation of effects of new antidiabetic medications in cardiovascular outcome trials
24. Biased ligand of the angiotensin II type 1 receptor in patients with acute heart failure: a randomized, double-blind, placebo-controlled, phase IIB, dose ranging trial (BLAST-AHF)
25. Serelaxin in addition to standard therapy in acute heart failure: rationale and design of the RELAX‐AHF‐2 study
26. Serelaxin in acute heart failure patients with and without atrial fibrillation: a secondary analysis of the RELAX-AHF trial.
27. Identifying Subpopulations with Distinct Response to Treatment Using Plasma Biomarkers in Acute Heart Failure: Results from the PROTECT Trial
28. Sex differences in early dyspnea relief between men and women hospitalized for acute heart failure: insights from the RELAX-AHF study
29. Cardiopoietic cell therapy for advanced ischemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial
30. Cause of Death in Patients With Acute Heart Failure: Insights From RELAX-AHF-2
31. Drug development in oncology and devices—lessons for heart failure drug development and approval? a review
32. Effects of serelaxin in acute heart failure patients with renal impairment: results from RELAX-AHF.
33. A combined clinical and biomarker approach to predict diuretic response in acute heart failure
34. Optimization of Evidence-Based Heart Failure Medications After an Acute Heart Failure Admission
35. Effective medications can work only in patients who take them: implications for post acute heart failure care
36. Cell Therapy Improves Quality-of-Life in Heart Failure: Outcomes From a Phase III Clinical Trial
37. Safety Indicators in Patients Receiving High-intensity Care After Hospital Admission for Acute Heart Failure: The STRONG-HF Trial
38. C‐reactive protein, inflammation and short‐term mortality in acute heart failure.
39. Trajectories of Changes in Renal Function in Patients with Acute Heart Failure
40. Early vs. late worsening heart failure during acute heart failure hospitalization: insights from the PROTECT trial
41. International differences in clinical characteristics, management, and outcomes in acute heart failure patients: better short‐term outcomes in patients enrolled in Eastern Europe and Russia in the PROTECT trial
42. Cell Therapy Improves Quality-of-Life in Heart Failure: Outcomes From a Phase III Clinical Trial.
43. Optimization of Evidence-Based Heart Failure Medications After an Acute Heart Failure Admission: A Secondary Analysis of the STRONG-HF Randomized Clinical Trial.
44. Effective medications can work only in patients who take them: Implications for post‐acute heart failure care.
45. Noncardiac comorbidities and intensive up‐titration of oral treatment in patients recently hospitalized for heart failure: insights from the STRONG‐HF trial
46. Prevalence, predictors and clinical outcome of residual congestion in acute decompensated heart failure
47. Site enrollment rate, outcomes, and study drug effects in a multicenter trial. Results from RELAX-AHF
48. Permutation criteria to evaluate multiple clinical endpoints in a proof-of-concept study: lessons from Pre-RELAX-AHF
49. Uptitrating Treatment After Heart Failure Hospitalization Across the Spectrum of Left Ventricular Ejection Fraction
50. Safety, tolerability and efficacy of up‐titration of guideline‐directed medical therapies for acute heart failure in elderly patients: a sub‐analysis of the STRONG‐HF randomized clinical trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.